TRAF2 antibody (N-Term)
Quick Overview for TRAF2 antibody (N-Term) (ABIN201466)
Target
See all TRAF2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- Recognizes human TRAF2. Species cross-reactivity: mouse and rat.
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide TRAF2 16aa near the amino terminus of human TRAF2 (Genbank accession No. CAI15106).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
-
Approved: WB (0.5 - 1 μg/mL)
Usage: Suitable for use in Western Blot. Western Blot: 0.5-1 μg/mL. Positive control: Human liver tissue lysate. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.2, 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Short term: 4°C
Long term: Add glycerol (40-50%) -20°C.
-
-
- TRAF2 (TNF Receptor-Associated Factor 2 (TRAF2))
-
Alternative Name
- TRAP / TRAF2
-
Background
-
Name/Gene ID: TRAF2
Synonyms: TRAF2, MGC:45012, TRAP3 -
Gene ID
- 7186
-
UniProt
- Q12933
-
Pathways
- NF-kappaB Signaling, Apoptosis, Caspase Cascade in Apoptosis, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Positive Regulation of Endopeptidase Activity, Hepatitis C, Unfolded Protein Response, S100 Proteins
Target
-